Scopus h-index:22
Article:38
Review Article:12
Comment/Debate:10
Letter:2
Editorial:5
Selected Publications
- Corrigendum to Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis Kidney International Reports, Volume 8, Issue 1, January 2023, Pages 30–35 (Kidney International Reports (2023) 8(1) (30–35), (S2468024922018162), (10.1016/j.ekir.2022.10.004))
- Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis
- PD-1 inhibition in aged podocytes and glomerular disease
- KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
- IgA Nephropathy and Focal Segmental Glomerulosclerosis in a Patient With High-Risk Apolipoprotein L1 Genotype
- Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease
- Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis
- Oral Glucocorticoids for IgA Nephropathy
- Association of Vaccination with the Persistence of Post-COVID Symptoms
- Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis